Biomarkers and antithrombotic treatment in cervical artery dissection - Design of the TREAT-CAD randomised trial.
Christopher TraenkaHenrik GensickeSabine SchaedelinAndreas LuftMarcel ArnoldPatrik MichelGeorg KägiTimo KahlesChristian H NolteLars KellertSverre RosenbaumRoman SztaizelAlex BrehmChristoph StippichMarios PsychogiosPhilippe LyrerStefan T Engelternull nullPublished in: European stroke journal (2020)
TREAT-CAD is testing the non-inferiority of Aspirin versus vitamin K antagonists treatment in patients with symptomatic cervical artery dissection by combined clinical and magnetic resonance imaging outcomes.
Keyphrases
- magnetic resonance imaging
- coronary artery disease
- low dose
- computed tomography
- randomized controlled trial
- atrial fibrillation
- type diabetes
- adipose tissue
- cardiovascular events
- metabolic syndrome
- cardiovascular disease
- magnetic resonance
- open label
- study protocol
- antiplatelet therapy
- percutaneous coronary intervention